BioSpace News Archive

BioForest

EndoGastric Solutions Secures $30.5 Million In New Financing

EndoGastric Solutions, Inc.® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that it has secured $30.5 million in new financing led by existing EGS investors...

July 10, 2018
·
5 min read
BioForest

ADDING and REPLACING ARMADA Launches Global Attack on Antibiotic Resistance

Introducing a radical big-data tracking approach to stop the rise of ‘superbugs’

July 10, 2018
·
2 min read
New Study Shows 1.2 Million People in the United States Estimated to be Living with Parkinson’s Disease by 2030

A Parkinson’s Foundation study recently published in the scientific journal, npj Parkinson’s Disease, reveals findings from the most comprehensive estimate of Parkinson’s disease in the United States and Canada to date.

July 10, 2018
·
3 min read
Policy

Visura Technologies Receives FDA Clearance for the TEE Camera Assist Device System

Visura Technologies, a start-up medical device company based in Evanston, IL, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its TEE Camera Assist Device (TEECAD) System.

July 10, 2018
·
1 min read
Rimidi Closes $6.575 Million Series A with Strategic Investment from Eli Lilly

Rimidi, Inc., a digital health company that provides software and clinical analytics for chronic disease management, today announced it has raised $6.575 million in Series A-1 financing...

July 10, 2018
·
1 min read
Anthrax | A Pipeline Analysis Report 2018 | Technavio

Technavio has announced their latest pipeline analysis report on the anthrax market.

July 10, 2018
·
3 min read
Biotech Bay

Velos Spring analytics platform for clinical research rolls out with a collaborative approach

Velos, Inc. is rolling out its Velos Spring analytics platform for clinical research with a collaborative approach.

July 10, 2018
·
2 min read
BioCapital

ATCC launches new PCR-based Mycoplasma Detection Service

Ensures validity and reliability of data from cell culture-based research

July 10, 2018
·
2 min read
Business

Berlinger Group Presents Arrangements for the Future Provision of Its World-renowned Anti-doping Products

Distribution and further development of Berlinger anti-doping products to be entrusted to a foundation; Berlinger Board of Directors appoints new Group CEO

July 10, 2018
·
5 min read
Biotech Bay

SRI International Announces Drug Research Collaboration with Ionis Pharmaceuticals

SRI International announced a research agreement with Ionis Pharmaceuticals, combining SRI’s proprietary FOX Three Molecular Guidance cellular targeting system (MGS) with Ionis’ proprietary antisense drug-discovery platform.

July 10, 2018
·
1 min read